News

AddToAny

Google+ Facebook Twitter Twitter

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemotherapy to treat an aggressive form of adult leukem

Drugs developed to treat heart and blood vessel problems could be used in combination with chemotherapy to treat an aggressive form of adult leukemia.

The claim comes from new research led by the Francis Crick Institute.

The team discovered that acute myeloid leukemia (AML) causes bone marrow to “leak” blood, preventing chemotherapy being delivered properly.

Drugs that reversed bone marrow leaking boosted the effect of chemotherapy in mice and human tissue, providing a possible new combination therapy for AML patients.

Diana Passaro, lead author, said: “The cancer was damaging the walls of blood vessels responsible for delivering oxygen, nutrients, and chemotherapy. When we used drugs to stop the leaks in mice, we were able to kill the cancer using conventional chemotherapy.”

As the drugs are already in clinical trials for other conditions, it is hoped that they could be given the green light for AML patients in the future.

The study has been published in Cancer Cell.

bit.ly/BS_ OctNews6

Related Articles

“One-stop shops to speed up diagnosis”

"One-stop shop to speed up cancer diagnosis"

Special centres that are aimed at speeding up cancer diagnosis are being introduced across Englan

How did gonorrhoea become drug resistant?

How did gonorrhoea become drug resistant?

Mutations to the bacterium Neisseria gonorrhoea have been identified, that enable resistance to ceftriaxone, which could lead to the global spread of ceftriaxone-resistant “superbug” strains.

Gut bacteria drive autoimmune disease

Bacteria found in the small intestines of mice and humans can travel to other organs and trigger an autoimmune response, states a new paper.

Top